Antimicrobial resistance and over the counter use of drugs in Nepal

  15 June 2020

The risk and burden of AMR in Asia are disproportionately higher than any other continents because of high population growth triggering antimicrobial demand together with the unregulated antimicrobial use in both humans and animals, and the wide circulation of counterfeit and sub-standard medicines [4]. Asia is the most populous continent of the planet earth with the population of 4.5 billion and constitutes 60% of the world’s population with China and India together constituting more than two-third of the Asia’s population [5]. Together with the population density, current transition in economy, migration, high burden of infectious diseases and tropical diseases and the consequent demands and use of antimicrobials has made Asia a hub for the antimicrobial resistance [6]. The emerging resistance of antimicrobials in South Asia is intertwined with epidemiological, social, cultural and political characteristics of the nations. In this article, we will discuss the social, cultural and regulatory factors contributing to AMR and potential solutions by focusing on the context of Nepal.

Further reading: Journal of Global Health
Author(s): Sunil Pokharel and Bipin Adhikari
Effective Surveillance  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!